Northeast Region Consumer Price Index Data Released for April 2026 The AI Economy Reshapes the American Dream BlueCollar Workers May Emerge as Winners India Gains from Data Center Expansion While Largely Missing AI Chip Boom Microsoft and Anthropic in Talks for Custom AI Chip Supply Amid 5 Billion Investment SpaceX and OpenAI IPOs Could Surpass Berkshire Hathaway on Debut Day Prediction Markets Suggest US Consumer Sentiment Remains Strained Amid Inflation Geopolitical Conflicts and Trade Policy Uncertainty BSY Q1 2026 Earnings EPS Beats Estimates by Nearly 6 CANG Q4 2025 Earnings Massive EPS Miss Sends Stock Tumbling PSX Q1 2026 Earnings Strong Earnings Surprise Driven by Improved Refining Margins VINP Q1 2026 Earnings EPS Misses Estimates by 148 as Stock Declines IDT Q1 2026 Earnings Mixed Quarter as Earnings Miss Estimates but Stock Edges Higher Diebold Nixdorf Q1 2026 Earnings EPS Beat Drives Stock Gains Amid Revenue Disclosure Gaps United Microelectronics UMC Surges 1575 on Strong Momentum Key Levels to Watch Estrella Immunopharma Inc ESLA Shows Modest Uptick Amid Sector Stability Rain Enhancement Technologies RAIN Climbs 649 on Renewed Trading Interest PAMT CORP PAMT Surges 321 Key Levels and Market Sentiment Alarmcom Holdings ALRM Inches Higher as Stock Consolidates Near Support Ainos Director Lee TingChuan Disposes of Over 200K in Shares IHG Q4 2025 Earnings EPS Misses Estimates Stock Edges Lower GameStop GME Hovers Near Key Support Levels Amid Modest Gains ASPI Q4 2025 Earnings Massive EPS Shortfall but Stock Surges as Market Focuses on Pipeline Progress NEON Q1 2026 Earnings EPS Misses Estimates Amid Revenue Disclosure Gap SU Q1 2026 Earnings Strong EPS Beat Highlights Operational Efficiency Amid Market Challenges DOC Q1 2026 Earnings Massive EPS Beat Drives Strong Surprise Yet Stock Edges Lower MBINM Q1 2026 Earnings Preferred Shares Benefit from Strong EPS Beat Brandywine Realty Trust BDN Q1 2026 Earnings Modest Loss Surprise as Office REIT Navigates Market Headwinds Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings EPS Misses Estimates as Biotech Focuses on Clinical Pipeline